What Happened?
Newton, MA-based Pro Pharmaceuticals, Inc. appointed David Platt as Chief Technology Officer.
Date of management change: January 17, 2009
Newton, MA-based Pro Pharmaceuticals, Inc. appointed David Platt as Chief Technology Officer.
DAVANAT, the Company's lead product candidate, is a targeted therapeutic compound composed of a complex carbohydrate polymer. DAVANAT's mechanism of action is targeting lectins on the tumor cell surface.
David Platt was previously the CEO and President of Pro-Pharmaceuticals.
Press Release
Other IT executives who recently changed jobs as well: Lannigan Shannon, Radin Jeff, Rice Adam, Spencer Robert, Singh Baljinder, Evans Robert, Accinelli Daniel, Blanchette Scott, Linares Carlos, Walker Heather, Hicks Adam
You can find the full directory of IT executives here.
How would you like to connect with 15,000+ IT executives in charge of $ millions in IT budgets? Find details here.